Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Avancès C[au]:

[Not Available]. Murez T et al. Prog Urol. (2014)

Initial management of testicular cancer: practice survey among urologists and pathologists. Rigaud J et al. Clin Genitourin Cancer. (2014)

[Testicular germ cell tumors late relapses]. Durand X et al. Prog Urol. (2010)

Search results

Items: 50

1.

Facteurs de récidive après curage rétro-péritonéal pour tumeur germinale : étude rétrospective multicentrique.

Murez T, Durand X, Rivoire M, Fournier G, Dariane C, Rouprêt M, Lugagne J, Bosset P, Pignot G, Hetet J, Rigaud J, Safsaf R, Pfister C, Daste A, Sèbe P, Malavaud B, Bossavy J, Houlgatte A, Avances C, Camparo P, Flechon A, Culine S, Iborra F, Mottet N, Coloby P, Soulié M.

Prog Urol. 2014 Nov;24(13):865. doi: 10.1016/j.purol.2014.08.180. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461706
2.

[Management of testicular teratoma: update by the Oncology Committee of the French Urology Association, section of External Genital Organs (CCAFU-OGE)].

Avances C, Camparo P, Durand X, Flechon A, Murez T, Sebe P, Soulie M, Rigaud J; Oncology Committee of the French Urology Association, section of External Genital Organs (CCAFU-OGE).

Prog Urol. 2014 Dec;24(16):1050-3. doi: 10.1016/j.purol.2014.07.005. Epub 2014 Sep 8. French.

PMID:
25199728
3.

[CCAFU's contribution to the French National Cancer Institute's reference frame: Adrenal malignant tumors].

Sèbe P, Rigaud J, Avancès C, Brunaud L, Caillard C, Camparo P, Carnaille B, Durand X, Fléchon A, Murez T, Mathonnet M, Triponez F, Mirallié E, Coloby P, Soulié M; Les membres de l’AFCE; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S167-74. doi: 10.1016/S1166-7087(13)70054-X. French.

PMID:
24485291
4.

[CCAFU's contribution to the French National Cancer Institute's reference frame: Retroperitoneal sarcomas].

Avancès C, Rigaud J, Camparo P, Durand X, Sèbe P, Fléchon A, Murez T, Coloby P, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S161-6. doi: 10.1016/S1166-7087(13)70053-8. French.

PMID:
24485290
5.

[CCAFU Recommendations 2013: Testicular germ cell cancer].

Durand X, Rigaud J, Avancès C, Camparo P, Fléchon A, Murez T, Sèbe P, Culine S, Iborra F, Mottet N, Coloby P, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S145-60. doi: 10.1016/S1166-7087(13)70052-6. French.

PMID:
24485289
6.

[CCAFU Recommendations 2013: Penile cancer].

Rigaud J, Avancès C, Camparo P, Durand X, Fléchon A, Murez T, Sèbe P, Coloby P, Culine S, Iborra F, Mottet N, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S135-44. doi: 10.1016/S1166-7087(13)70051-4. French.

PMID:
24485288
7.

Initial management of testicular cancer: practice survey among urologists and pathologists.

Rigaud J, Durand X, Camparo P, Avances C, Culine S, Sebe P, Flechon A, Murez T, Soulie M; Comittee of Cancerology of Association of French Urology (CCAFU).

Clin Genitourin Cancer. 2014 Aug;12(4):292-9. doi: 10.1016/j.clgc.2013.12.002. Epub 2013 Dec 26.

PMID:
24461624
8.

Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.

Pignot G, Salomon L, Neuzillet Y, Masson-Lecomte A, Lebacle C, Patard JJ, Lunardi P, Rischmann P, Pasticier G, Bernhard JC, Cohen J, Timsit MO, Verkarre V, Peyronnet B, Verhoest G, Le Goux C, Zerbib M, Brecheteau F, Bigot P, Larre S, Murez T, Thuret R, Lacarriere E, Champy C, Roupret M, Comperat E, Berger J, Descazeaud A, Toledano H, Bastide C, Lavilledieu S, Avances C, Delage F, Valeri A, Molimard B, Houlgatte A, Gres P, Donnaint A, Kleinclauss F, Legal S, Doerfler A, Koutlidis N, Cormier L, Hetet JF, Colls P, Arvin-Berod A, Rambeaud JJ, Quintens H, Soulie M, Pfister C; Oncologic Committee of the French Association of Urology.

Ann Surg Oncol. 2014 Feb;21(2):684-90. doi: 10.1245/s10434-013-3340-8. Epub 2013 Oct 30.

PMID:
24170436
9.

[Postchemotherapy retroperitoneal lymphadenectomy for testicular cancer. Literature review by the Oncology Committee of the French Association of Urology, External Genitalia Group].

Durand X, Culine S, Camparo P, Avancès C, Sèbe P, Soulié M, Rigaud J; sous-comité organes génitaux externes du CCAFU.

Prog Urol. 2012 May;22(5):245-54. doi: 10.1016/j.purol.2011.10.004. Epub 2011 Nov 30. Review. French.

PMID:
22515919
10.

[Penile cancer in 2010: update from the Oncology Committee of the French Association of Urology: external genital organs group (CCAFU-OGE)].

Souillac I, Avances C, Camparo P, Culine S, Durand X, Haie-Meder C, Sebe P, Soulie M, Rigaud J.

Prog Urol. 2011 Dec;21(13):909-16. doi: 10.1016/j.purol.2011.08.031. Epub 2011 Sep 29. French.

PMID:
22118355
11.

[Natural history and management of retroperitoneal sarcoma: Review of the literature by the Oncology committee of the French association of urology].

Avancès C, Camparo P, Quenet F, Durand X, Culine S, Sèbe P, Soulié M, Rigaud J; Comité de Cancérologie de l'Association Française d'Urologie - groupe Organes Génitaux Externes (CCAFU-OGE).

Prog Urol. 2011 Jul;21(7):441-7. doi: 10.1016/j.purol.2010.09.029. Epub 2011 Apr 14. Review. French.

PMID:
21693353
12.

[Malignant tumors of the adrenal: contribution to the repository CCAFU INCa].

Sèbe P, Rigaud J, Avancès C, Brunaud L, Caillard C, Camparo P, Carnaille B, Culine S, Durand X, Mathonnet M, Mirallie E, Soulié M; Oncology Committee of the French Association of Urology (CCAFU).

Prog Urol. 2010 Nov;20 Suppl 4:S310-6. doi: 10.1016/S1166-7087(10)70047-6. French. No abstract available.

PMID:
21129649
13.

[Recommendations Onco-Urology 2010: Germ cell testicular tumors.].

Durand X, Rigaud J, Avances C, Camparo P, Culine S, Iborra F, Mottet N, Sèbe P, Soulié M; Oncology Committee of the French Association of Urology (CCAFU).

Prog Urol. 2010 Nov;20 Suppl 4:S297-309. doi: 10.1016/S1166-7087(10)70046-4. French. No abstract available.

PMID:
21129648
14.

[Retroperitoneal sarcoma: contribution to the repository CCAFU INCA.].

Avancès C, Rigaud J, Bui B, Camparo P, Culine S, Durand X, Sèbe P, Soulié M; Oncology Committee of the French Association of Urology (CCAFU).

Prog Urol. 2010 Nov;20 Suppl 4:S290-6. doi: 10.1016/S1166-7087(10)70045-2. French. No abstract available.

PMID:
21129647
15.

[Recommendations Onco-Urology 2010: Malignancies of the penis].

Rigaud J, Avancès C, Camparo P, Culine S, Durand X, Iborra F, Mottet N, Sèbe P, Soulié M; Oncology Committee of the French Association of Urology (CCAFU).

Prog Urol. 2010 Nov;20 Suppl 4:S279-89. doi: 10.1016/S1166-7087(10)70044-0. French. No abstract available.

PMID:
21129646
16.

[Testicular germ cell tumors late relapses].

Durand X, Avances C, Flechon A, Mottet N; sous-comité OGE du comité de cancérologie de l'Association française d'urologie.

Prog Urol. 2010 Jun;20(6):416-24. doi: 10.1016/j.purol.2010.02.004. Epub 2010 Apr 22. Review. French.

PMID:
20538205
17.

Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, de la Taille A, Culine S, Blancou H, Cristol JP, Michel F, Sardet C, Fajas L.

Mol Cancer Ther. 2010 Jun;9(6):1740-54. doi: 10.1158/1535-7163.MCT-09-1064. Epub 2010 Jun 8.

18.

[Treatment of lymph nodes in epidermoid carcinoma of the penis: review of literature by the Committee of Cancerology of the French Association of Urology-External Genital Organs Group (CCAFU-OGE)].

Marconnet L, Bouchot O, Culine S, Avances C, Rigaud J; membres du CCAFU-OGE.

Prog Urol. 2010 May;20(5):332-42. doi: 10.1016/j.purol.2009.09.015. Epub 2009 Nov 4. Review. French.

PMID:
20471577
19.

[Histological features and principles of treating testicle tumors in the elderly subject].

Camparo P, Durand X, Avances C, Culine S, Segui B, Rigaud J; Membres du GELU-Groupe d'Etude des Lésions Urologiques; Membres du CCAFU.

Prog Urol. 2009 Nov;19 Suppl 3:S142-6. doi: 10.1016/S1166-7087(09)73361-5. French.

PMID:
20123499
20.

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S, Fajas L.

PLoS One. 2009 Oct 26;4(10):e7542. doi: 10.1371/journal.pone.0007542.

21.

[Primary urethral carcinoma. Epidemiology, diagnosis and pathology. Guidelines from the French Urological Association Cancer committee].

Avancès C, Lesourd A, Michel F, Mottet N; les membres du sous-comité organes génitaux externes du comité de cancérologie de l'AFU.

Prog Urol. 2009 Mar;19(3):165-9. doi: 10.1016/j.purol.2008.12.004. Epub 2009 Feb 8. Review. French.

PMID:
19268253
22.

[What about lombo-aortic curage in the treatment of testicle cancer?].

Iborra F, Avances C, Culine S, Houlgatte A, Mottete N.

Ann Urol (Paris). 2007 Jun;41(3):116-26. Review. French.

PMID:
18260272
23.

[Penile tumors].

Mottet N, Avances C, Bastide C, Culine S, Iborra F, Lesourd A, Michel F, Rigaud J.

Prog Urol. 2007 Nov;17(6):1049-62. French. No abstract available.

PMID:
18153987
24.

[Testicular tumors].

Mottet N, Culine S, Iborra F, Avances C, Bastide C, Lesourd A, Michel F, Rigaud J.

Prog Urol. 2007 Nov;17(6):1035-45. French. No abstract available.

PMID:
18153986
25.

Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.

Culine S, El Demery M, Lamy PJ, Iborra F, Avancès C, Pinguet F.

J Urol. 2007 Sep;178(3 Pt 1):844-8; discussion 848. Epub 2007 Jul 16.

PMID:
17631339
26.

[Long-term morbidity of living donor kidney harvesting].

Gres P, Avances C, Iborra F, Mourad G, Guiter J.

Prog Urol. 2007 Apr;17(2):194-8. French.

PMID:
17489317
27.

Liver metastases in prostate carcinoma: clinical characteristics and outcome.

Pouessel D, Gallet B, Bibeau F, Avancès C, Iborra F, Sénesse P, Culine S.

BJU Int. 2007 Apr;99(4):807-11. Epub 2006 Nov 28.

28.

DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.

Boireau S, Buchert M, Samuel MS, Pannequin J, Ryan JL, Choquet A, Chapuis H, Rebillard X, Avancès C, Ernst M, Joubert D, Mottet N, Hollande F.

Carcinogenesis. 2007 Feb;28(2):246-58. Epub 2006 Jul 8.

PMID:
16829686
29.

[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?].

El Demery M, Pouessel D, Avancès C, Iborra F, Rebillard X, Faix A, Ségui B, Delbos O, Ayuso D, Culine S.

Prog Urol. 2006 Jun;16(3):320-3. French.

PMID:
16821344
30.

Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.

Culine S, Iborra F, Mottet N, Avancès C, de Graeve B, Volpé P, Vignoud J, Bringer JP, Marroncle M, Le Pellec L, Ayuso D, Jansen E, Faix A, Rebillard X.

Am J Clin Oncol. 2006 Apr;29(2):148-52.

PMID:
16601433
31.

Prognostic factors for first recurrence in patients with retroperitoneal sarcoma.

Avancès C, Mottet N, Mahatmat A, Chapuis E, Serre I, Culine S.

Urol Oncol. 2006 Mar-Apr;24(2):94-6.

PMID:
16520270
32.

[Primary penile tumor: local treatment].

Avances C, Pabot Du Chatelard P, Mottet N.

Prog Urol. 2005 Sep;15(4 Suppl 2):817-22. Review. French. No abstract available.

PMID:
16382982
33.

[Recommendations: diagnosis of malignant penile tumors].

Avances C, Iborra F, Rocher L, Mottet N.

Prog Urol. 2005 Sep;15(4 Suppl 2):810-6. Review. French. No abstract available.

PMID:
16382981
34.

[Anatomic review of the penis].

Avances C, Iborra F, Bastide C.

Prog Urol. 2005 Sep;15(4 Suppl 2):799-800. French. No abstract available.

PMID:
16382978
35.

Intermittent androgen castration: a biological reality during intermittent treatment in metastatic prostate cancer?

Mottet N, Lucas C, Sene E, Avances C, Maubach L, Wolff JM.

Urol Int. 2005;75(3):204-8.

PMID:
16215305
36.

[Penile tumors].

Mottet N, Avances C, Bastide C, Culine S, Ibora F, Kouri G, le Sourd A, Michel F, Pabot du Chatelard P, Rocher L; Comité de Cancérologie de l'Association Française d'Urologie.

Prog Urol. 2004 Nov;14(4 Suppl 1):903, 905-11. French. No abstract available.

PMID:
15779653
37.

[Testicular tumors].

Mottet N, Avances C, Bastide C, Culine S, Ibora F, Kouri G, le Sourd A, Michel F, Rocher L; Comité de Cancérologie de l'Association Française d'Urologie.

Prog Urol. 2004 Nov;14(4 Suppl 1):891, 893-901. Review. French. No abstract available.

PMID:
15779652
38.

[Solitary fibrous tumours of the kidney].

Gres P, Avances C, Ben Naoum K, Chapuis H, Costa P.

Prog Urol. 2004 Feb;14(1):65-6. Review. French.

PMID:
15098756
39.

[Calculous renal failure and pregnancy].

Forget S, Avances C, Dubon O, Mares P, Costa P.

Prog Urol. 2003 Sep;13(4):673-4. French.

PMID:
14650303
40.

[Prostate cancer and acute disseminated intravascular coagulation. Therapeutic management based on three cases].

Avances C, Oumaya C, Granger V, Dubon O, Gris JC, Culine S, Costa P.

Prog Urol. 2003 Apr;13(2):308-12. French.

PMID:
12765072
41.

[Erectile dysfunction: knowledge, wishes and attitudes. Results of a French study of 5.099 men aged 17 to 70].

Costa P, Avances C, Wagner L.

Prog Urol. 2003 Feb;13(1):85-91. French.

PMID:
12703359
42.

Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines.

Orio F Jr, Térouanne B, Georget V, Lumbroso S, Avances C, Siatka C, Sultan C.

Mol Cell Endocrinol. 2002 Dec 30;198(1-2):105-14.

PMID:
12573820
43.

[Non-typhus Salmonella urinary tract infections].

Viale S, Avances C, Bennaoum K, Costa P.

Prog Urol. 2002 Dec;12(6):1297-8. Review. French.

PMID:
12545644
44.

[Efficacy of suburethral TVT in cases of stress urinary incontinence associated with severe sphincter insufficiency. Report of 22 cases].

Djelouat T, Avances C, Dubon O, Viale S, Boukaram M, Costa P.

Prog Urol. 2002 Dec;12(6):1251-5. French.

PMID:
12545633
45.

Prompt resolution of acute disseminated intravascular coagulation with docetaxel and cisplatin in hormone refractory prostate cancer.

Avancès C, Jacot W, Sénesse P, Culine S.

J Urol. 2002 Oct;168(4 Pt 1):1496. No abstract available.

PMID:
12352431
46.

Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens.

Avancès C, Georget V, Térouanne B, Orio F, Cussenot O, Mottet N, Costa P, Sultan C.

Mol Cell Endocrinol. 2001 Nov 26;184(1-2):13-24.

PMID:
11694337
47.

A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects.

Térouanne B, Tahiri B, Georget V, Belon C, Poujol N, Avances C, Orio F Jr, Balaguer P, Sultan C.

Mol Cell Endocrinol. 2000 Feb 25;160(1-2):39-49.

PMID:
10715537
48.

[Androgen-independent prostate carcinoma and androgen-receptor: recent progress in molecular genetics].

Sultan C, Terouanne B, Tahiri B, Lumbroso S, Avances C, Orio F Jr.

Bull Cancer. 1999 Jul-Aug;86(7-8):618-21. French.

49.

[Concomitant radiochemotherapy in invasive bladder tumors].

Mottet N, Di Palma M, Avances C, Costa P, Jardin A, Misset JL.

Bull Cancer. 1997 Apr;84(4):405-11. Review. French.

50.

[Neuroendocrine tumor of the bladder apropos of a case. Review of the literature].

Avances C, Mottet N, Chapuis H, Dagues F, Ben Naoum K, Louis JF, Costa P, Marty-Double C, Navratil H.

Prog Urol. 1997 Feb;7(1):85-7. Review. French.

PMID:
9116745

Supplemental Content

Loading ...
Support Center